BALANCE SHEET ABSTRACT AND COMPANY’S

GENERAL BUSINESS PROFILE

I Registration No. : 2 1 2 6 State Code : 0 4

Balance Sheet Date : 3 1 0 3 2 0 1 0

II Capital raised during the year (Rs. in thousands)

Public Issue : N I L Right Issue : N I L

Bonus Issue : N I L Private Placement : N I L

III Position of Mobilisation and Deployment of Funds (Rs. in thousands)

Total Liabilities : 1 8 4 7 7 9 4 9 Total Assets : 1 8 4 7 7 9 4 9

Sources of Funds
Paid-up Capital : 4 2 3 0 9 2 Reserves & Surplus : 8 3 8 5 4 2 4

Secured Loans : 3 6 4 6 4 1 6 Unsecured Loans : 1 5 7 7 5 4 1

Net Deferred Tax Liability : 6 2 0 7 0 9

Application of Funds
Net Fixed Assets : 6 3 1 0 0 5 3 Investments : 2 3 1 4 7 5 9

Net Current Assets : 6 0 2 8 3 7 0 Misc. Expenditure : N I L

Accumulated Losses : N I L

IV Performance of Company (Rs. in thousands)

Turnover : 1 3 8 6 1 0 3 8 Total Expenditure : 1 1 4 4 2 3 4 9

Profit Before Tax : 3 5 0 8 1 2 1 Profit After Tax : 2 0 7 3 6 7 7

Earning per Share (in Rs.) : 2 4 . 5 1 Dividend rate % : 1 2 0 . 0 0 %

(Annualised)

V Generic Names of Three Principal Products / Services of Company (as per monetary terms)

Item Code No. (ITC Code) : 3 0 0 4 3 1 . 0 1

Product Description : Insulin

Item Code No. (ITC Code) : 3 0 0 4 9 0 . 4 9

Product Description : Domperidone

Item Code No. (ITC Code) : 3 0 0 4 9 0 . 4 9

Product Description : Alprazolam

Mahesh Agrawal Sudhir Mehta

VP (Legal) & Company Secretary Chairman

Ahmedabad Samir Mehta

6th May, 2010 Managing Director

54